Hope this link helps? You can check out the different reports and make yr own decisions as analysts are also human. The major shareholders are listed in reports. Also check the SGX to see who are buying/selling. I don’t follow this stock and not vested. Good luck.
www.remisiers.org/index.php?option=com_c...6:research&Itemid=16
[hr]
[hisey 16-05-2012]:
1stly, So do u know is there any hse that give a sell call for CMZ??
2ndly, what's the probability that this CMZ may have accounting problems issue??
Shocking, today fell another 7.5 cts to 61.5 cts.
Many people say CMZ and YZJ are the 2 best S-CHIPs listed here, so why CMZ crashed so badly these few days when other much lousier earnings S-chips's share prices were much more reslient??
[hr]
[hisey 15-05-2012]:
Other much more lousy earnings S-CHIPS such as cosco and yanlord(poor property outlook this year) their share prices also much higher than their 52 week low but this China Minzhong is now below 70 cts very near to it's all-time low of 66.5 cts. 52-week is $1.81
Heard templeton and another fund increased their stakes in this CMZ last mth, is it?
I don’t understand why the CFO is holding the shares in trust for his bosses. Other thing is, what happens when the CFO quits the company or there is a fallout?
China Minzhong Holdings Limited (“Minzhong (BVI)”) is solely owned by the Chief Financial Officer, Siek Wei Ting (100%) of which Siek Wei Ting is holding an aggregate of 100% of the Shares in Minzhong (BVI) on trust for the CEO and Executive Director, Lin Guo Rong (42.86%), Chief Operation Officer, Wang Dazhang (28.57%) and our Chief Technology Officer, Huang Bing Hui (28.57%).
Having disappointed the market and given the continued negative sentiments towards S-Chips in general, we believe its crucial for the company to deliver what they have guided the market during the briefing after the 3Q’12 results briefing where management expects to grow full year ending June’12 profit by 20% and to sustain 15-20% profit growth rate going forward.
• Unfortunately, our BUY recommendation ahead of its 3Q’12 result release did not turn out well with the stock having declined a significant 30+% since.
• But like Sino Grandness which also disappointed the market in 4Q’11 but subsequently delivered with a robust 1Q’12 performance and saw its stock price rebound nicely, if China Minzhong can do the same as guided by management, we believe it is a value buy with the stock at 2.5x PE and 0.5x price to book.
Macquarie Research has a positive view (although JP Morgan has a downright negative view).
"We continue to see MINZ as a deep value stock. However, our ability to forecast earnings accurately has materially decreased from this set of results. As such, we take a more conservative stance by lowering our estimates below the company’s guidance. Nevertheless, the stock is trading on 3.3x CY12E PER vs. peers at 6x. We believe the valuation has priced in a great deal of
uncertainty."
12-month target of Macquarie is S$1.40. Looks lofty to me.
Is this JP Morgan the one incurred heavy loss recently?
[hr]
[viviene 21-05-2012]:
Macquarie Research has a positive view (although JP Morgan has a downright negative view).
"We continue to see MINZ as a deep value stock. However, our ability to forecast earnings accurately has materially decreased from this set of results. As such, we take a more conservative stance by lowering our estimates below the company’s guidance. Nevertheless, the stock is trading on 3.3x CY12E PER vs. peers at 6x. We believe the valuation has priced in a great deal of
uncertainty."
12-month target of Macquarie is S$1.40. Looks lofty to me.
NextInsight
a hub for serious investors
